Champions Oncology, Inc. CSBR

What this company does

We are a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. We currently have approximately 1,500 PDX Models in our TumorBank that we believe reflect the characteristics of patients who enroll in clinical trials (late stage, pretreated and metastatic). Our SaaS business is centered around our proprietary software platform and data tool, Lumin Bioinformatics ("Lumin"), which contains comprehensive information derived from our research services and clinical studies and is sold to customers on an annual subscription basis. Revenue from this business has grown at an average annual growth rate of 12% since 2019 and represents the primary source of our current revenue stream. As of July 15, 2026, we had 214 full-time employees, including 103 with doctoral or other advanced degrees. We were incorporated as a merger and acquisition company under the laws of the State of Delaware on June 4, 1985, under the name "International Group, Inc."

Written from the business description in Champions Oncology, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 July 2026. Every sentence was checked against that document before publication.